PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 87 filers reported holding PMV PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $376,950 | -1.8% | 61,394 | +0.1% | 0.00% | – |
| Q2 2023 | $383,825 | +138465.0% | 61,314 | +5.7% | 0.00% | – |
| Q1 2023 | $277 | -43.6% | 57,998 | +2.8% | 0.00% | -100.0% |
| Q4 2022 | $491 | -99.9% | 56,414 | +1.4% | 0.00% | 0.0% |
| Q3 2022 | $662,000 | -12.1% | 55,659 | +5.4% | 0.00% | 0.0% |
| Q2 2022 | $753,000 | +30.5% | 52,821 | +90.8% | 0.00% | 0.0% |
| Q1 2022 | $577,000 | -2.9% | 27,690 | +7.7% | 0.00% | 0.0% |
| Q4 2021 | $594,000 | -19.6% | 25,707 | +3.6% | 0.00% | 0.0% |
| Q3 2021 | $739,000 | -8.2% | 24,811 | +5.3% | 0.00% | 0.0% |
| Q2 2021 | $805,000 | +74.6% | 23,554 | +68.0% | 0.00% | 0.0% |
| Q1 2021 | $461,000 | -46.2% | 14,018 | +0.6% | 0.00% | 0.0% |
| Q4 2020 | $857,000 | – | 13,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |